Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Publication year range
1.
Obes Surg ; 31(1): 159-169, 2021 Jan.
Article in English | MEDLINE | ID: mdl-32728839

ABSTRACT

PURPOSE: Circadian misalignment has been associated with an increased risk of overweight and obesity, as well as changes in metabolic parameters. This study evaluated the association between social jet lag (SJL), a measure of circadian misalignment, and anthropometric, metabolic and food intake outcomes 6 months after bariatric surgery. MATERIALS AND METHODS: A total of 122 bariatric patients were included (77% female, aged 33 years (range 28-41); 79.5% underwent Roux-en-Y gastric bypass). Anthropometric, food consumption and SJL were evaluated in the preoperative evaluation and in the third and sixth months after surgery. SJL was calculated based on the absolute difference between the mid-sleep time on weekends and weekdays. Generalised estimating equations and linear regression were performed to evaluate the associations between mean SJL exposure and the outcomes. RESULTS: The interaction between SJL and follow-up time negatively influenced the evolution of weight (p = 0.01), BMI (p = 0.04) and insulin levels (p = 0.01). SJL had an effect on intake of calories (p = 0.001), carbohydrate (p = 0.005) and total (p = 0.007), monounsaturated (p = 0.03) and polyunsaturated fat (p < 0.001). Linear regression showed a negative association between mean SJL exposure over the 6 months and the percentage of weight loss (coefficient = - 0.30, p = 0.006), body weight loss (kg) (coefficient = - 0.17, p = 0.03) and the reduction of BMI (coefficient = - 0.24, p = 0.007). CONCLUSIONS: SJL was negatively associated with anthropometric, metabolic and food consumption outcomes 6 months after bariatric surgery. Future studies with longer follow-up are needed to confirm these findings. TRIAL REGISTRATION: Clinical Trials.gov : NCT03485352.


Subject(s)
Bariatric Surgery , Gastric Bypass , Obesity, Morbid , Adult , Eating , Female , Humans , Male , Obesity, Morbid/surgery , Weight Loss
2.
Surg Endosc ; 34(10): 4388-4394, 2020 10.
Article in English | MEDLINE | ID: mdl-31624939

ABSTRACT

BACKGROUND: Endoscopic sleeve gastroplasty (ESG) is an option for patients with Class I and II obesity or patients who refuse to undergo a laparoscopic bariatric surgery. The aims of this study are as follows: (1) to demonstrate a short-term outcome after primary ESG and (2) to compare the effectiveness of weight loss between Class I and Class II obesity patients. METHODS: Patients undergoing ESG at four bariatric centers in Brazil between April 1, 2017 and December 31, 2018 were prospectively enrolled in the study (BMI 30.0-39.9 kg/m2). ESG was performed using Overstitch (Apollo Endosurgery, Austin, TX). Descriptive analysis, t test, Chi-square test, and Mann-Whitney test were used to present the results. RESULTS: A total of 233 patients underwent primary ESG. The mean age and BMI of the patients were 41.1 years and 34.7 kg/m2, respectively. Following ESG, the mean percentage of total weight loss (TWL) was 17.1% at 6 months and 19.7% at 12 months. Percentage of excess BMI loss (EBMIL) was 47.3% at 6 months and 54.8% at 12 months after ESG. The mean EBMIL was significantly greater among patients with Class I obesity than those with Class II obesity at 6 (51.1% vs. 43.7%) and 12 months (60.2% vs. 49.2%). One patient experienced bleeding during the procedure that was managed with sclerotherapy. CONCLUSION: Short-term results suggest that ESG is a safe and effective option for patients with Class I and II obesity.


Subject(s)
Endoscopy , Gastroplasty/adverse effects , Adult , Bariatric Surgery , Body Mass Index , Brazil , Female , Gastroplasty/methods , Humans , Male , Obesity/surgery , Time Factors , Treatment Outcome , Weight Loss
3.
Rev. bras. cir. cardiovasc ; 19(3): 314-319, jul.-set. 2004. ilus, tab
Article in Portuguese | LILACS | ID: lil-416947

ABSTRACT

OBJETIVO: A função do Sistema Nervoso Intrínseco Cardíaco e o seu papel na doença cardíaca permanecem pobremente compreendidos. Sabe-se que o cloreto de benzalcônio (CB) induz a desnervação intrínseca do tubo digestivo. O objetivo deste estudo foi tentar produzir um modelo experimental de desnervação intrínseca do coração utilizando o CB. MÉTODO: Trinta ratos Wistar foram submetidos à aplicação intrapericárdica de CB (0,3 por cento) e trinta animais controle receberam a solução salina. Após 15 dias, os animais foram divididos em três grupos, com 10 animais tratados e 10 controles em cada. Os animais do grupo I foram submetidos a estudo radiológico e histopatológico. A área cardíaca e o índice cardiotorácico (ICT) foram medidos nas radiografias. Os animais do grupo II foram submetidos a estudo hemodinâmico com registro da pressão arterial, freqüência cardíaca e débito cardíaco. No grupo III, a integridade da inervação parassimpática extrínseca do coração foi avaliada por estimulação vagal direita. O sistema de condução foi avaliado pelo ECG basal. RESULTADOS: A aplicação de CB acarretou aumento do ICT, da área cardíaca, pressão arterial e débito cardíaco, bem como do peso ponderal e do fígado. Nestes animais, a análise histopatológica mostrou redução do número de neurônios atriais e congestão passiva crônica do fígado. A estimulação vagal não mostrou diferenças entre os grupos experimentais. CONCLUSAO: A ablação do sistema nervoso intrínseco propiciou o aparecimento de cardiopatia dilatada com insuficiência cardíaca direita e esquerda. Esse modelo experimental inédito deverá nortear futuros estudos na tentativa da elucidação da relação entre lesão neuronal e miocardiopatia.


Subject(s)
Animals , Rats , Autonomic Nervous System , Cardiomyopathy, Dilated , Myocardial Contraction , Heart Conduction System , Animal Experimentation , Benzalkonium Compounds
SELECTION OF CITATIONS
SEARCH DETAIL
...